-transparent.png){kind=logo}
Potassium and magnesium deficiencies usually coexist and represent a risk factor for cardiac arrhythmias. Serum levels--in particular of magnesium--are inconclusive for establishing a possible electrolyte deficiency. Basic treatment of arrhythmia should therefore include the administration of potassium and magnesium, since the benefit is great, and the possible side effects is negligible. A placebo-controlled study involving patients with cardiac arrhythmias revealed that appreciably fewer ventricular asystoles occurred after three weeks of treatment with potassium and magnesium aspartate, even when serum levels were within the normal range prior to initiating treatment. Patients older than 50, and those with previous coronary heart disease and/or myocardial infarction derived particular benefit from this form of treatment. CONCLUSIONS These results underscore the key role played by potassium and magnesium in the treatment of cardiac arrhythmias.
M Manz, and
R Susilo
February 1986,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Manz, and
R Susilo
January 1986,
Magnesium,
M Manz, and
R Susilo
January 2000,
Wiener medizinische Wochenschrift (1946),
M Manz, and
R Susilo
January 1981,
Acta medica Scandinavica. Supplementum,
M Manz, and
R Susilo
October 1960,
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
M Manz, and
R Susilo
October 1971,
Medizinische Klinik,
M Manz, and
R Susilo
January 1978,
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
M Manz, and
R Susilo
August 1968,
Die Medizinische Welt,
M Manz, and
R Susilo
May 1984,
Clinical chemistry,
M Manz, and
R Susilo
September 1967,
Die Medizinische Welt,
